Premarket clinical evidence strength and recalls of high-risk therapeutic medical devices

Authors

• Maryam Mooghali, Yale University
• Faaizah Arshad, University of California, San Francisco
• Vinay K Rathi, The Ohio State University
• Kushal T Kadakia, Massachusetts General Hospital
• Alexander O Everhart, Washington University School of Medicine in St. Louis
• Joseph S Ross, Yale University
• Sanket S Dhruva, University of California, San Francisco

Journal

JAMA Health Forum

Publication Date

8-7-2026

Volume

7

Issue

8

First Page

e262626

Document Type

Open Access Publication

DOI

10.1001/jamahealthforum.2026.2626

Rights and Permissions

Mooghali M, Arshad F, Rathi VK, et al. Premarket Clinical Evidence Strength and Recalls of High-Risk Therapeutic Medical Devices. JAMA Health Forum. 2026;7(8):e262626. doi:10.1001/jamahealthforum.2026.2626. This is an open access article distributed under the terms of the CC-BY-NC-ND License, which does not permit alteration or commercial use, including those for text and data mining, AI training, and similar technologies. © 2026 Mooghali M et al. JAMA Health Forum.

Recommended Citation

Mooghali, Maryam; Arshad, Faaizah; Rathi, Vinay K; Kadakia, Kushal T; Everhart, Alexander O; Ross, Joseph S; and Dhruva, Sanket S, "Premarket clinical evidence strength and recalls of high-risk therapeutic medical devices." JAMA Health Forum. 7, 8. e262626 (2026).
https://digitalcommons.wustl.edu/oa_4/7185

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.